Adam Hansard
Chief Commercial Officer, Applied Therapeutics, Inc.
Companies
- Applied Therapeutics, Inc.Chief Commercial Officer Mar 5, 2020 to Mar 18, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Applied Therapeutics, Inc.732,919 shares2Mar 14, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 14, 2024Sold 48,871 shares at $5.39 of Applied Therapeutics, Inc.2
- Dec 21, 2023Granted 400,000 shares of Applied Therapeutics, Inc.3
- Nov 30, 2023Sold 965 shares at $1.97 of Applied Therapeutics, Inc.4
- Sep 27, 2023Sold 9,720 shares at $2.70 of Applied Therapeutics, Inc.5
- Jan 11, 2023Granted 300,000 shares of Applied Therapeutics, Inc.6
- Jan 11, 2023Sold 4,495 shares at $0.91 of Applied Therapeutics, Inc.6
- Jan 7, 2022Granted 31,700 shares of Applied Therapeutics, Inc.7
- Dec 14, 2021Granted 31,700 shares of Applied Therapeutics, Inc.8
- Dec 14, 2021Granted 31,700 shares of Applied Therapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Dec 22, 2023
- 4SEC EDGARForm 4 filed Dec 1, 2023
- 5SEC EDGARForm 4 filed Sep 29, 2023
- 6SEC EDGARForm 4 filed Jan 13, 2023
- 7SEC EDGARForm 4 filed Jan 11, 2022
- 8SEC EDGARForm 4 filed Dec 16, 2021
- 9SEC EDGARForm 4 filed Jan 11, 2022